NOTE: The following includes references to in the online news media. If you are interested in seeing the full article you will need to contact archives department of the source publication. We do not have copies of any articles described on this site.

Aastrom Biosciences (ASTM)

Aastrom Biosciences

Aastrom rises; Syntel, Noble fall
[excerpt] Among advancers, Aastrom Biosciences, an Ann Arbor-based developer of cell-based therapies, rose 12 cents, or 9.8 percent, to $1.34. ... [/excerpt]
On 28 Dec 2004 in DetNews.com

Biotech, pharma higher; stem-cell companies rise
[excerpt] Inc. and fellow stem-cell researcher Aastrom Biosciences standing out on the strength of significant advances in their shares. Following ... [/excerpt]
On Dec 27, 2004 in Investor's Business Daily (subscription)

Aastrom Biosciences Announces Appointment of Dr. Gunter Rosskamp ...
[excerpt] ANN ARBOR, Mich., and BERLIN, Dec. 9 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NasdaqSC ... de. Aastrom Biosciences, Inc. ... [/excerpt]
On Dec 9, 2004 in Yahoo News (press release)

Aastrom Biosciences Announces Appointment of Dr. Gunter Rosskamp ...
[excerpt] ANN ARBOR, Mich., and BERLIN, December 09, 2004 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. ... Rosskamp.Zellera@t-online.de. Aastrom Biosciences, Inc. ... [/excerpt]
On Dec 9, 2004 in PharmaLive.com (press release)

Bellwether Report Adds ZICA, STEM, UBET and ASTM to Our Aggressive ...
[excerpt] ...next year. Aastrom Biosciences (NASDAQ: ASTM) is trading up 7% today, similar to the influx that StemCells Inc is seeing. The speculation ... [/excerpt]
On Dec 27, 2004 in ArriveNet (press release)

X-Rite, Collins pace state gains
[excerpt] Among the index's biggest losers, Ann Arbor-based Aastrom Biosciences Inc., which develops cell therapies, fell 2 cents to $1.14. ... [/excerpt]
On Dec 22, 2004 in DetNews.com

Aastrom leads as stocks slip
[excerpt] Among the index's biggest gainers, Ann Arbor-based Aastrom Biosciences, which develops cell therapies, rose 3 cents, or 2.6 percent, to $1.17. ... [/excerpt]
On Dec 20, 2004 in DetNews.com

Biotech, pharma end higher; Nitromed up
[excerpt] American patients. But the biggest gainers were stem cell researchers Aastrom Biosciences (ASTM) and StemCells Inc. (STEM), advancing ... [/excerpt]
On Dec 23, 2004 in Investor's Business Daily (subscription)

Handleman up, Aastrom declines
[excerpt] Among decliners, Aastrom Biosciences, an Ann Arbor-based developer of cell-based therapies, fell 2 cents, or 1.7 percent, to $1.13. Borders Group Inc., the No. ... [/excerpt]
On Dec 14, 2004 in DetNews.com

Borders rises, La-Z-Boy falls
[excerpt] Aastrom Biosciences Inc., which develops cell therapies and is also based in Ann Arbor, gained 4 cents, or 4 percent, to $1.09. ... [/excerpt]
On Dec 9, 2004 in DetNews.com

Visteon, Collins pace state drop
[excerpt] Among the index's biggest gainers, Ann Arbor-based Aastrom Biosciences Inc., which develops cell-therapy systems, rose 3 cents, or 2.9 percent, to $1.08. ... [/excerpt]
On Dec 6, 2004 in DetNews.com

Aastrom paces state stock gains
[excerpt] Among advancers, Ann Arbor-based Aastrom Biosciences, a developer of cell-based therapies, rose 12 cents, or 12 percent, to $1.13. ... [/excerpt]
On Nov 29, 2004 in DetNews.com

Gurus Log On To A Chinese Web Portal
[excerpt] The company has $2 in cash per share. Aastrom Biosciences (nasdaq: ASTM - news - people ) is a more speculative stem cell play. ... [/excerpt]
On Dec 7, 2004 in Forbes

The Biotech Market Rebounds in November
[excerpt] ..."Indeed, while publicly traded stem cell firms such as Geron (GERN), StemCells (STEM), and Aastrom Biosciences (ASTM) saw the value of their shares rise in ... [/excerpt]
On Dec 3, 2004 in Yahoo News (press release)

Area researchers fear stem cell brain drain
[excerpt] Investments in academic research often breed new companies. Ann Arbor-based Aastrom Biosciences Inc. and Nephros Therapeutics Inc. ... [/excerpt]
On Nov 28, 2004 in Ann Arbor News

MORNING UPDATE: Man Securities issues alerts for ORCL, HD, X, ADI ...
[excerpt] ...accepted by voters in 2006. Stem cell stocks to watch include Aastrom Biosciences and StemCells Inc. Receive incisive economic/market ... [/excerpt]
On Nov 30, 2004 in PR Newswire (press release)

Energy Devices leads stocks rise
[excerpt] ...$5.98. Aastrom Biosciences Inc., an Ann Arbor-based developer of cell-based therapies, fell 4 cents, or 3.5 percent, to $1.09. Farmington ... [/excerpt]
On Dec 1, 2004 in DetNews.com,